Zhejiang Medicine Co., Ltd. (SHA:600216)

China flag China · Delayed Price · Currency is CNY
17.64
-0.74 (-4.03%)
Mar 9, 2026, 3:00 PM CST
14.17%
Market Cap 16.72B
Revenue (ttm) 8.96B
Net Income (ttm) 1.24B
Shares Out 947.91M
EPS (ttm) 1.30
PE Ratio 13.60
Forward PE 16.33
Dividend 0.37 (2.01%)
Ex-Dividend Date Jul 21, 2025
Volume 47,558,635
Average Volume 36,332,649
Open 18.35
Previous Close 18.38
Day's Range 17.50 - 18.58
52-Week Range 11.60 - 18.58
Beta 0.65
RSI 67.03
Earnings Date Apr 24, 2026

About Zhejiang Medicine

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and medical products in China and internationally. The company offers synthetic vitamin E, natural vitamin E, β-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also provides fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products. In addition, the company offers injectable levofloxacin lactate, injectable vancomycin hydrochloride injections, and injectable teicoplanin produc... [Read more]

Sector Healthcare
Founded 1997
Employees 5,815
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600216
Full Company Profile

Financial Performance

In 2024, Zhejiang Medicine's revenue was 9.38 billion, an increase of 20.29% compared to the previous year's 7.79 billion. Earnings were 1.16 billion, an increase of 170.11%.

Financial Statements

News

There is no news available yet.